drugset / Trial / NCT00760825
A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children
Phase 4
Completed
200 enrolled
International Vaccine Institute
Christian Medical College, Vellore, India · collabShantha Biotechnics Limited · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether the killed bivalent (O1 and O139)whole cell oral cholera vaccine(Shanchol™) is safe and effective in the treatment of Vibrio cholerae.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-04
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shanchol | Vaccine | 1.5 ml | Oral |